Drug Trial Radar · NCT04091945
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Jan 27, 2020
Primary completion
Feb 22, 2021
Study completion Feb 22, 2021
Sponsor
- Lead sponsor
- Lumosa Therapeutics Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 17, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, double-blind, single-dose, randomized, and placebo-controlled prospective Phase IIa clinical study, designed to evaluate LT3001 drug product versus placebo/control in subjects with AIS.
Conditions
- Acute Ischemic Stroke
Interventions
LT3001 Drug ProductDrug
Active comparator
PlaceboDrug
Placebo comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Percentage of Subject Have Symptomatic Intracranial Hemorrhage (sICH) of a Single Dose LT3001 Drug Product in Subjects With AIS.Time frame: Within 36 hours
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
University of Kentucky Chandler Medical Center
Lexington, Kentucky
JFK Neuroscience Institute, JFK Medical Center
Edison, New Jersey
The Ohio State University - Wexner Medical Center
Columbus, Ohio
Chattanooga Center for Neurologic Research
Chattanooga, Tennessee
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
Linkou Chang Gung Memorial Hospital
New Taipei City, Taiwan
Taipei Medical University - Shuang Ho Hospital
New Taipei City, Taiwan
China Medical University Hospital
Taichung, Taiwan
Taichung Veterans General Hospital
Taichung, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.